Ms Nina Kjellson

KANDO id: 10608

Bio

Nina Kjellson has been part of InterWest's life sciences team since 2002, focusing primarily on investments in biopharmaceuticals. She is a board member of Alvine Pharmaceuticals, Cebix, CNS Therapeutics, Eiger Biopharmaceuticals, Lycera, PrimeraDx and Trius Therapeutics. Kjellson led InterWest's investment in APT Pharmaceuticals where she is an observer on the board and is also involved in InterWest's investment in TESARO. Prior to joining InterWest, Kjellson was an investment manager at Bay City Capital, a life sciences merchant bank, and a research associate at Oracle Partners, a healthcare-focused hedge fund. Kjellson began her career conducting health policy and survey research with the Kaiser Family Foundation.She also serves on the Advisory Board of The Consumer Med Summit. Kjellson received a B.A. in human biology from Stanford University.

Career


InterWest Partners

Diversified venture capital firm based in Silicon Valley.
Life Sciences
Email: [email protected]

Education